ライフサイエンスコーパス: gastroschisis

1 reatments for Hirschsprung's Disease(HD) and gastroschisis.

2 phageal atresia, and ruptured omphalocele or gastroschisis.

3 we examined the association between GUI and gastroschisis.

4 evidence that UTIs may increase the risk of gastroschisis.

5 PAHs among mothers who are >/= 20 years and gastroschisis.

6 e of asthma antiinflammatory medications and gastroschisis.

7 the periconceptional period and the risk of gastroschisis.

8 r 1997, the authors treated 80 children with gastroschisis.

9 re has been a decrease in primary closure of gastroschisis.

10 en 1993 and 1997, 38 children presented with gastroschisis.

11 rin use in early pregnancy increases risk of gastroschisis.

12 -5.26]), hypospadias (1.96 [0.98-3.92]), and gastroschisis (3.19 [0.95-10.77]).

13 ophageal fistula (66% to 87%, P < 0.001) and gastroschisis (76% to 89%, P < 0.001).

14 thout cleft palate (14%), omphalocele (60%), gastroschisis (76%), Down syndrome (43%), trisomy 18 (61

15 omplicated appendicitis (14.1% [$51702402]), gastroschisis (9.5% [$34940331]), gastrostomy (5.8% [$21

16 t this hypothesis, we examined neonates with gastroschisis, a congenital abdominal wall defect that l

17 ity of ACLP(-/-) mice die perinatally due to gastroschisis, a severe disruption of the anterior abdom

18 n elevated statistically significant risk of gastroschisis (adjusted odds ratio = 2.06, 95% confidenc

19 ween estimated occupational PAH exposure and gastroschisis among children whose mothers were employed

20 nt association between occupational PAHs and gastroschisis among mothers >/= 20 years of age [odds ra

21 e-control study of mothers of offspring with gastroschisis and age-matched controls.

22 inhaled beta2-agonists for cleft palate and gastroschisis and found a potential new signal for renal

23 life events and social support with risks of gastroschisis and hypospadias, using data from the Natio

24 population before transplant were intestinal gastroschisis and intestinal dysmotility syndromes in ch

25 A 2-year-old boy born with gastroschisis and intestinal malrotation lost his entire

26 al drug use is a significant risk factor for gastroschisis and is one of a constellation of potential

27 Abdominal wall defects comprising both gastroschisis and omphalocele remain a source of signifi

28 causes of intestinal and liver failure were gastroschisis and parenteral nutrition.

29 ough/cold/analgesic medications and risks of gastroschisis and SIA.

30 Gastroschisis and small intestinal atresia (SIA) are bir

31 Gastroschisis and small-intestinal atresia may be partic

32 y factors associated with the development of gastroschisis and to evaluate the mode, timing, and loca

33 en a number of new prenatal interventions in gastroschisis, and a better understanding of gestational

34 testinal atresia, necrotizing enterocolitis, gastroschisis, and midgut volvulus.

35 The cases included 381 infants with isolated gastroschisis, and the controls were 4,121 liveborn infa

36 rimary EBV infection was not associated with gastroschisis, but observed associations with both IgM a

37 lable, the effects of disease on the risk of gastroschisis cannot be ruled out.

38 From 1998 to 2010, mothers of 249 gastroschisis cases and 7,104 controls were interviewed

39 Data from gastroschisis cases and control infants were obtained fr

40 periconceptional period among mothers of 593 gastroschisis cases, 1,142 male hypospadias cases, and 4

41 From 1995 to 1999, the mothers of 206 gastroschisis cases, 126 SIA cases, and 798 controls in

42 The adjusted odds ratios for gastroschisis for a 4-point increase in the stress index

43 inal wall defects (primarily omphalocele and gastroschisis) has improved, but controversy remains reg

44 Outcomes for infants with gastroschisis have paralleled advances made in neonatal

45 Previous studies of gastroschisis have suggested that risk is increased for

46 have been associated with increased risk of gastroschisis in 2 studies.

47 d maternal occupational exposure to PAHs and gastroschisis in offspring.

48 to PAHs during pregnancy is associated with gastroschisis in offspring; however, to our knowledge, n

49 r primary treatment of HD in review one, and gastroschisis in review two.

50 the hypothesis that the birth prevalence of gastroschisis is positively associated with use of recre

51 partment syndrome has made staged closure of gastroschisis more common in the authors' practice.

52 l age is the strongest known risk factor for gastroschisis, most cases are born to mothers >/= 20 yea

53 the most common cause in the PG followed by gastroschisis (n=5), intestinal atresia (n=5), and necro

54 ositive) and anophthalmia/microphthalmia and gastroschisis (negative).

55 eft palate (OR, 1.63; 95% CI, 1.05-2.52) and gastroschisis (OR, 1.89; 95% CI, 1.12-3.20) had signific

56 utcomes are currently investigated in HD and gastroschisis research so as to counter this heterogenei

57 icant risk of reporting bias exist in HD and gastroschisis research.

58 Gastroschisis risk is highest in offspring of young wome

59 edrine has previously been shown to increase gastroschisis risk, findings of this study raise questio

60 tomegalovirus IgG did not appear to increase gastroschisis risk.

61 We determined that patients with gastroschisis show high systemic levels of inflammatory

62 Thirty gastroschisis studies were eligible for inclusion in the

63 Using a mouse model of gastroschisis, we observed higher numbers of eosinophils

64 tically significant adjusted odds ratios for gastroschisis were associated with first-trimester use o

65 Risks of gastroschisis were elevated for use of aspirin (odds rat

66 Most were Latino children with gastroschisis who received multivisceral grafts.

67 ation at the hospital level was greatest for gastroschisis (WIQR, $48471; median, $111566 [IQR, $9119